Skip to main content
eScholarship
Open Access Publications from the University of California

Daphnetin: A Novel Anti-Helicobacter pylori Agent.

  • Author(s): Wang, Genzhu
  • Pang, Jing
  • Hu, Xinxin
  • Nie, Tongying
  • Lu, Xi
  • Li, Xue
  • Wang, Xiukun
  • Lu, Yun
  • Yang, Xinyi
  • Jiang, Jiandong
  • Li, Congran
  • Xiong, Yan Q
  • You, Xuefu
  • et al.
Abstract

Background

Antibiotic-resistant H. pylori was increasingly found in infected individuals, which resulted in treatment failure and required alternative therapeutic strategies. Daphnetin, a coumarin-derivative compound, has multiple pharmacological activities.

Methods

The mechanism of daphnetin on H. pylori was investigated focusing on its effect on cell morphologies, transcription of genes related to virulence, adhesion, and cytotoxicity to human gastric epithelial (GES-1) cell line.

Results

Daphnetin showed good activities against multidrug resistant (MDR) H. pylori clinical isolates, with minimal inhibitory concentration (MIC) values ranging from 25 to 100 μg/mL. In addition, daphnetin exposure resulted in H. pylori morphological changes. Moreover, daphnetin caused increased translocation of phosphatidylserine (PS), DNA damage, and recA expression, and RecA protein production vs. control group. Of great importance, daphnetin significantly decreased H. pylori adhesion to GES-1 cell line vs. control group, which may be related to the reduced expression of colonization related genes (e.g., babA and ureI).

Conclusions

These results suggested that daphnetin has good activity against MDR H. pylori. The mechanism(s) of daphnetin against H. pylori were related to change of membrane structure, increase of DNA damage and PS translocation, and decrease of H. pylori attachment to GES-1 cells.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View